Literature DB >> 1234624

Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

C T Griffiths.   

Abstract

The effect of tumor bulk resection on survival was studied in 102 patients with stages II and III ovarian cancer. A multiple linear regression equation provuded both simultenaous control of multiple confounding variables and an assessment of these variables as independent predictors of survival. The most important factors were the histologic grade of the tumor and the size of the largest residual tumor mass after operation. Survival time was uniformly poor if the diameter of the largest residual tumor mass exceeded 1.5 cm irrespective of total tumor volume (mean=12.7 months, SE=1.6 mo). Survival time was inversely proportional to residual mass size under 1.6 cm, and surgery improved survival relative to reduction in mass size below this limit. Extensive resections of tumor bulk with failure to remove all masses greater than 1.5 cm in diameter did not influence survival. Surgery provides optimum benefit when all gross tumor can be excised safely.

Entities:  

Mesh:

Year:  1975        PMID: 1234624

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  115 in total

1.  Interval robotic cytoreduction following neoadjuvant chemotherapy in advanced ovarian cancer.

Authors:  Sarah A Ackroyd; Sajeena Thomas; Cynthia Angel; Richard Moore; Philip J Meacham; Brent DuBeshter
Journal:  J Robot Surg       Date:  2017-06-19

Review 2.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 3.  The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse.

Authors:  E Saladino; F Fleres; S Irato; C Famulari; A Macrì
Journal:  Updates Surg       Date:  2013-08-27

4.  Outcome of Bowel Resection in Women with Advanced Ovarian Carcinoma.

Authors:  Ajit Sebastian; Anitha Thomas; Gigi Varghese; Bijesh Yadav; Rachel Chandy; Abraham Peedicayil
Journal:  Indian J Surg Oncol       Date:  2018-07-20

Review 5.  The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review.

Authors:  Salvatore Giovanni Vitale; Ilaria Marilli; Melissa Lodato; Alessandro Tropea; Antonio Cianci
Journal:  Updates Surg       Date:  2013-05-08

Review 6.  When is it safe to omit surgery in primary peritoneal cancer with small volume disease?

Authors:  Rachel Pounds; Sean Kehoe
Journal:  Curr Oncol Rep       Date:  2015-08       Impact factor: 5.075

Review 7.  Current drug treatment guidelines for epithelial ovarian cancer.

Authors:  P C Lorigan; T Crosby; R E Coleman
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 8.  Operative management of primary epithelial ovarian cancer.

Authors:  Mario M Leitao; Dennis S Chi
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

9.  Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Ramez N Eskander; James Kauderer; Krishnansu S Tewari; Robert S Mannel; Robert E Bristow; David M O'Malley; Stephen C Rubin; Gretchen E Glaser; Chad A Hamilton; Keiichi Fujiwara; Warner K Huh; Frederick Ueland; Jean-Marie Stephan; Robert A Burger
Journal:  Gynecol Oncol       Date:  2018-03-15       Impact factor: 5.482

10.  Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma.

Authors:  Sean C Dowdy; Ralitsa T Loewen; Giovanni Aletti; Simone S Feitoza; William Cliby
Journal:  Gynecol Oncol       Date:  2008-04-01       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.